David L. Kemmerly - 29 Mar 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Apr 2022, 20:57:33 UTC
Prior SEC filing
22 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer R. Guckert, pursuant to a power of attorney

Key filing fact

David L. Kemmerly filed Form 4 for AMEDISYS INC (AMED) on 04 Apr 2022.

Key facts

  • This page summarizes David L. Kemmerly's Form 4 filing for AMEDISYS INC (AMED).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Apr 2022, 20:57.

Change

  • Previous filing in this sequence was filed on 22 Feb 2022.
  • Current net transaction value: -$443,285.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMED transaction

Common Stock

Sale

Transaction value
$3,503
Shares
-20
Change %
-0.11%
Price
$175.16
Shares after
18,816
Date
29 Mar 2022
Ownership
Direct
Footnotes
F1, F2
AMED transaction

Common Stock

Sale

Transaction value
$360,977
Shares
-2,037
Change %
-11%
Price
$177.21
Shares after
16,779
Date
29 Mar 2022
Ownership
Direct
Footnotes
F1, F2, F3
AMED transaction

Common Stock

Sale

Transaction value
$78,805
Shares
-443
Change %
-2.6%
Price
$177.89
Shares after
16,336
Date
29 Mar 2022
Ownership
Direct
Footnotes
F1, F2, F4
AMED holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
506
Date
29 Mar 2022
Ownership
Through 401(k) Plan
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Footnote F2

The total amount of shares beneficially owned includes 292 shares held in an employee stock purchase plan account.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.66 to $177.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.66 to $178.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

Footnote F5

The information in this report is based on a plan statement dated as of December 31, 2021.

SEC remarks

Chief Legal & Government Affairs Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .